2-(4-Chloro-benzoylamino)-4-ethyl-5-methyl-th iophene-3-carboxylic acid methyl ester, 98%, 250mg

methyl 3-(cyclooctylamino)-2-methylpropanoate, 95.0%, 2g

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride, 95.0%, 1g

6-(Diethylamino)nicotinaldehyde, 97.0%, 100mg

2-Amino-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one, 97%, 5g

1,1,1,3,3,3-Hexafluoroisopropyl methacrylate (stabilized with MEHQ), 99.0%, 25g

VORAPAXAR, 95%, 5mg

1-(6-Chloro-5-methylpyridin-3-yl)ethanone, 95.0%, 250mg

2-Hydroxypyrimidine Hydrochloride>98.0%(HPLC)(T)250g

Ammonium ((1R,3S,4S,7R)-3-bromo-1,7-dimethyl-2-oxobicyclo[2.2.1]heptan-7-yl)methanesulfonate, 95.0%, 1g

Chlorodimethylphenylsilane>96.0%(GC)25mL

2-Bromo-3-trifluoromethyl-benzenethiol, 95.0%, 1g

Methyl 6-chloro-1H-pyrrolo[2,3-b]pyridine-3-carboxylate, 95.0%, 1g